Literature DB >> 9890792

Effects of anticonvulsant drugs on the cerebral enzymes metabolizing GABA.

M C Sawaya1, R W Horton, B S Meldrum.   

Abstract

The effect of anticonvulsant drugs on the activity of enzymes responsible for the further metabolism of GABA has been studied in mouse brain homogenates. Slight inhibition (5 to 20%) of GABA-T activity was seen with chlordiazepoxide (0.1 mM), ethosuximide (0.1 mM) and di-n-propylacetate (0.1 mM). No anticonvulsant drug (even at a concentration of 10 mM) produced inhibition comparable to that seen with amino-oxyacetic acid (65% at 0.01 mM). Succinic semialdehyde dehydrogenase activity was inhibited by 10 to 20% at low concentrations (0.01 to 0.1 mM) of diazepam, carbamazepine, beclamide, acetazolamide, and di-n-propylacetate, and by 40% or more at high concentrations (2.5 to 10.0 mM) of diazepam, phenobarbital, carbamazepine, beclamide, and di-n-propylacetate. Interference with the further metabolism of GABA may contribute to the antiepileptic action of drugs or to the acute neurological toxicity of anticonvulsant agents.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 9890792     DOI: 10.1111/j.1528-1157.1975.tb04747.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  16 in total

1.  Effect of diphenylhydantoin on gamma aminobutyric acid (GABA) and succinate activity in rat Purkinje cells.

Authors:  E Hitchcock; T Gabra-Sanders
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-06       Impact factor: 10.154

Review 2.  Prospects for the development of epigenetic drugs for CNS conditions.

Authors:  Moshe Szyf
Journal:  Nat Rev Drug Discov       Date:  2015-05-22       Impact factor: 84.694

Review 3.  Disposition of anticonvulsants in childhood.

Authors:  J I Morrow; A Richens
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

Review 4.  Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.

Authors:  K Gale; M Casu
Journal:  Mol Cell Biochem       Date:  1981-09-25       Impact factor: 3.396

Review 5.  Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.

Authors:  Rosilla F Bachmann; Robert J Schloesser; Todd D Gould; Husseini K Manji
Journal:  Mol Neurobiol       Date:  2005-10       Impact factor: 5.590

6.  Mood stabilizer psychopharmacology.

Authors:  Todd D Gould; Guang Chen; Husseini K Manji
Journal:  Clin Neurosci Res       Date:  2002-11-14

7.  Stiff-man syndrome with central and peripheral nervous manifestations.

Authors:  H Nyland; S I Mellgren; A G Frövig
Journal:  J Neurol       Date:  1978-12-07       Impact factor: 4.849

8.  Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion.

Authors:  P Loli; M E Berselli; F Frascatani; F Muratori; M Tagliaferri
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

9.  "In vivo" administration of valproate decreases t-[35S]butylbicyclophosphorothionate binding in the rat brain.

Authors:  A Concas; M P Mascia; E Sanna; G Santoro; M Serra; G Biggio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

Review 10.  Valproate-associated hepatotoxicity and its biochemical mechanisms.

Authors:  M J Eadie; W D Hooper; R G Dickinson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.